Rede D'Or Advances in Profit and Challenges Selic at 14%

Rede D’Or (RDOR3) surprised the market by posting an adjusted net income of R$ 1.3 billion in the second quarter of 2026, representing an 8.5% expansion compared to the same period of the previous year, demonstrating operational resilience in a challenging corporate environment. This result puts the country's largest exchange-listed hospital network in the spotlight, proving that assets with strong pricing power and high capillarity can shield their margins even when the cost of money reaches restrictive levels for the rest of the economy. While the macroeconomic scenario displays a Selic rate targeting 14.00% per year, dropping 1.75% in the 7-day trend, and the 12-month accumulated IPCA reaches 4.44% with a downward bias of 4.31% in the 30-day reading, the supplementary health sector navigates its own dynamics linked to bed efficiency and loss ratios. At the same time, the exchange rate trades at R$ 5.16 per dollar, accumulating a 1.81% rise in 7 days, making imported hospital supplies more expensive, which makes the company's operational advance even more meritorious from a cost perspective. The company's performance gains additional relevance when cross-referenced with the portal's recent archive, which registers a clear division in corporate sentiment with a predominance of four negative news items to only two positive ones, showing that companies focused on operational efficiency and intrinsic value, aligned with Graham and Buffett's tradition of safety, can distance themselves from the volatility of more leveraged companies. This dynamic corroborates the analysis that the current market punishes businesses dependent on cheap debt and rewards those capable of generating cash consistently, as observed in recent solid balance sheets from the infrastructure and essential services sector. The expansion of Ebitda and net income of the hospital giant reflects rigorous control of administrative costs and optimization in the occupancy of its proprietary network, mitigating the risks associated with rising working capital costs and persistent inflationary pressure. However, investors must closely monitor net debt and the maturation of newly inaugurated hospitals, since any slowdown in demand for corporate health plans could compress operating margins in the coming quarters, requiring caution in pricing the exchange-traded asset. For the 30-day horizon, a consolidation of the company's stock quotation in the current range is projected, reflecting the assimilation of the quarterly balance sheet by large institutional funds. In 90 days, the trend will directly depend on the disclosure of new sector loss ratio indicators and the trajectory of medical inflation, while in the 180-day horizon analysts' focus will fall on the company's ability to maintain the pace of net profit growth in an environment of still restrictive interest rates. For individual investors, the moment requires discipline and focus on diversification, avoiding concentrated allocations in a single regulated sector; the practical recommendation is to evaluate entry into shares of resilient companies only through fractioned and periodic contributions (dollar-cost averaging strategy). According to Ray Dalio's school of credit and liquidity cycles, understanding which stage of the macroeconomic cycle the company operates in is fundamental to separating conjunctural noise from long-term value, ensuring your assets are protected.